Effects of EMPA and SIRT1 modulation on SIRT1, NRF-1, and PINK1 protein expression in H9c2 cells. (IMAGE)
Caption
(A–D) Representative Western blots and quantification of SIRT1, NRF-1, and PINK1 protein expression in HG-cultured H9c2 cells with or without EMPA treatment. (E–H) Representative Western blots and quantification of SIRT1, NRF-1, and PINK1 protein expression in H9c2 cells with or without Res treatment. (I–L) Representative Western blots and quantification of SIRT1, NRF-1, and PINK1 protein expression in HG-cultured H9c2 cells treated with EMPA alone or in combination with EX527. (M) Western blot analysis of SIRT1 knockdown efficiency following transfection with si-NC or si-SIRT1. (N–Q) Representative Western blots and quantification of SIRT1, NRF-1, and PINK1 protein expression in si-NC- and si-SIRT1-transfected cells with or without EMPA treatment. Data are from 3–4 independent experiments. *P < 0.05, †P < 0.01, ‡P < 0.001. Cropped blots are shown; membranes were cut before incubation with primary antibodies. CON: Control; EMPA: Empagliflozin; HG: High glucose; NRF-1: Nuclear respiratory factor 1; PINK1: PTEN-induced kinase 1; Res: Resveratrol; SIRT1: Sirtuin 1; si-NC: Scrambled negative-control siRNA; si-SIRT1: SIRT1-specific siRNA.
Credit
Cardiology Discovery
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND